Farms.com Home   Ag Industry News

Saskatchewan Premier Brad Wall highlighting local ingredients during province-wide tour

Wall kicked off the Saskatchewan Ingredients Tour on Monday

By Diego Flammini
Assistant Editor, North American Content
Farms.com

Saskatchewan Premier Brad Wall is conducting a province-wide tour of different processing plants and organizations that use ingredients produced by local farmers.

The Saskatchewan Ingredients Tour began Monday with visits to CanMar Grain Products and NutraSun Foods.

Wall said the tour highlights Saskatchewan’s growing strength in value-added food processing.

 “There are now more than 300 food companies operating in the province that generate more than $4 billion in revenues and employ about 5,000 people,” he said in a Feb. 13 release.

“Their tremendous success demonstrates that Saskatchewan’s economy is stronger, more durable and more diversified than ever. Our province is no longer just a primary producer of grains, oilseeds and other resources. Throughout Saskatchewan, companies are adding value to what we grow and in the process creating jobs and opportunity.”

In addition to the impact the companies have locally, their presence is being felt around the globe.

According to the release, Harvest Meats in Yorkton, Sask. provides hot dogs to Safeco Field where baseball’s Seattle Mariners play their home games. Saskatchewan flax is used in cookies at Shanghai Disneyland and local oats are used in Cheerios.

And Saskatchewan lentils play an important part in Indian cuisine.

“Ninety per cent of India’s lentil imports, and more than 60 per cent of its pea imports, are grown by Saskatchewan farmers,” Wall said in the release.

The tour is expected to last a few weeks. Premier Wall will be posting photos from the tour to his Facebook page.

Farms.com has reached out to producers in Saskatchewan to get their thoughts on the tour.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.